Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02029001
Title Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: My Own Specific Treatment (MOST plus)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Centre Leon Berard
Indications

Advanced Solid Tumor

Therapies

Durvalumab + Tremelimumab

Olaparib

Pazopanib

Nilotinib

Age Groups: adult | senior
Covered Countries

Additional content available in CKB BOOST